Dana-Farber Cancer Institute
This internship focuses on a cancer initiation project to identify the impact of the immune system at the very birth of a tumor. The role involves learning molecular biology techniques, cell culture, and tissue harvest. The intern will help set up in vitro co-culture assays with mammary epithelial organoids and CD8 T cells to generate a platform for assessing T cell resistance mechanisms.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
1947
Dana‑Farber Cancer Institute, based in Boston, MA, is a world‑leading cancer center specializing in adult and pediatric cancer treatment and research. Its physician‑scientists deliver multidisciplinary patient care and develop many of the most advanced therapies, including targeted treatments and clinical trials. Dana‑Farber combines cutting‑edge laboratory research with translational programs, prevention and survivorship services, and education to improve outcomes. Patients and clinicians turn to Dana‑Farber for its expertise, comprehensive care teams, and strong research pipeline.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dana-Farber Cancer Institute.
DNA company aids Horry Co. in solving cold cases
Nov 26, 2025
Senior Associate Scientist - Discovery Research, Regeneron Cell Medicines
Regeneron Pharmaceuticals
Postdoctoral Fellow
University of North Carolina System
Scientist II
AbbVie
Research Technician II - Pediatrics Hematology & Oncology
Washington University in St. Louis
Research Associate or Senior Research Associate
Bristol Myers Squibb
Scientist I/II, In Vitro Pharmacology
Alloy Therapeutics